FDA draft guidance on controlled correspondence reflects GDUFA III commitments
Regulatory NewsJoanne S. Eglovitch
ComplianceHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy